During the ' Lightning Round' of Mad Money Thursday night, Jim Cramer weighed in on Teva Pharmaceuticals (TEVA) : "No. We have Bristol-Myers Squibb (BMY) , why do we need Teva?" Let's revisit the charts of BMY to see if the bulls can push BMY to new all-time highs.
More from Investing
We're also focused on buying bonds that can survive a bad downturn. This gives us a game plan going into a recession.
Let's check out the charts of EMR to see if there might be more risk ahead.
We continue to see elevated risk levels for this market.
I continue to hunt for buys but I am staying highly selective which can make you feel left out when the market is acting this frothy.
The restaurant operator missed on earnings but doubled its dividend, while the aircraft parts supplier reveals it will be restating results over two years.